SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-024102
Filing Date
2020-11-17
Accepted
2020-11-17 16:39:00
Documents
15
Period of Report
2020-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vcyt20201116_8k.htm   iXBRL 8-K 27597
2 EXHIBIT 99.1 VERACYTE PRESS RELEASE DATED NOVEMBER 17, 2020 ex_214430.htm EX-99.1 13588
7 ex_214430img001.jpg GRAPHIC 3221
  Complete submission text file 0001437749-20-024102.txt   182917

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20201117.xsd EX-101.SCH 3702
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcyt-20201117_def.xml EX-101.DEF 11588
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20201117_lab.xml EX-101.LAB 15468
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20201117_pre.xml EX-101.PRE 11742
8 EXTRACTED XBRL INSTANCE DOCUMENT vcyt20201116_8k_htm.xml XML 2570
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 201321612
SIC: 8071 Services-Medical Laboratories